Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Hatzl, S; Geiger, C; Kriegl, L; Reinisch, A; Wölfler, A; Apfaltrer, G; Keldorfer, M; Rödl, S; Hoenigl, M; Eller, P; Krause, R.
Pulmonary Coinfection of Pneumocystis jirovecii and Aspergillus Species.
Open Forum Infect Dis. 2025; 12(2): ofaf018
Doi: 10.1093/ofid/ofaf018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Hatzl Stefan
-
Krause Robert
- Co-Autor*innen der Med Uni Graz
-
Apfaltrer Georg
-
Eller Philipp
-
Hönigl Martin
-
Keldorfer Markus
-
Kriegl Lisa
-
Reinisch Andreas
-
Roedl Siegfried
-
Wölfler Albert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In this multicenter study of 387 patients who were immunocompromised, 4.5% with invasive pulmonary aspergillosis also had Pneumocystis jirovecii pneumonia. Predictors of coinfection included elevated β-D-glucan and prolonged corticosteroid use. Coinfection correlated with reduced 30-day survival (22% vs 57%), suggesting that early identification and prophylaxis may improve outcomes.
- Find related publications in this database (Keywords)
-
aspergillosis
-
immunocompromised patients
-
invasive pulmonary aspergillosis
-
PCP-IPA coinfection
-
Pneumocystis jirovecii